Thema
Antibodies, Monoclonal, Humanized
55.245
Journal Article
46.025
Antibodies, Monoclonal
23.452
Research Support, Non-U.S. Gov't
16.712
Review
9.836
Case Reports
8.687
Bevacizumab
8.118
2S9ZZM9Q9V
8.105
Antineoplastic Agents
7.957
EC 2.7.10.1
6.993
Letter
6.333
Angiogenesis Inhibitors
6.308
Trastuzumab
5.362
P188ANX8CK
5.349
Randomized Controlled Trial
4.956
Multicenter Study
4.829
Vascular Endothelial Growth Factor A
4.026
pembrolizumab
3.922
DPT0O3T46P
3.900
Receptor, ErbB-2
3.834
Comment
3.813
Adalimumab
3.578
FYS6T7F842
3.561
tocilizumab
3.255
I031V2H011
3.244
Research Support, N.I.H., Extramural
3.209
Cetuximab
3.185
PQX0D8J21J
3.170
Comparative Study
2.922
Clinical Trial, Phase II
2.867
Antirheumatic Agents
2.822
Immunosuppressive Agents
2.786
Tumor Necrosis Factor-alpha
2.778
Immunoglobulin G
2.525
ErbB Receptors
2.334
Antineoplastic Agents, Immunological
2.159
Infliximab
2.050
B72HH48FLU
2.033
Clinical Trial, Phase III
2.014
Ranibizumab
1.920
ZL1R02VT79
1.918
Alemtuzumab
1.772
3A189DH42V
1.770
VEGFA protein, human
1.674
Klinische Studie
1.639
ERBB2 protein, human
1.609
Clinical Trial, Phase I
1.565
Anti-Inflammatory Agents
1.552
Fluorouracil
1.528
U3P01618RT
1.528
mehr ...